HomeCompareFRGAP vs JNJ

FRGAP vs JNJ: Dividend Comparison 2026

FRGAP yields 7.95% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRGAP wins by $98861.57M in total portfolio value
10 years
FRGAP
FRGAP
● Live price
7.95%
Share price
$25.15
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$98861.60M
Annual income
$96,529,713,962.19
Full FRGAP calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — FRGAP vs JNJ

📍 FRGAP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRGAPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRGAP + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRGAP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRGAP
Annual income on $10K today (after 15% tax)
$675.94/yr
After 10yr DRIP, annual income (after tax)
$82,050,256,867.86/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, FRGAP beats the other by $82,050,252,830.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRGAP + JNJ for your $10,000?

FRGAP: 50%JNJ: 50%
100% JNJ50/50100% FRGAP
Portfolio after 10yr
$49430.81M
Annual income
$48,264,859,356.04/yr
Blended yield
97.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FRGAP
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
Altman Z
1.6
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRGAP buys
0
JNJ buys
0
No recent congressional trades found for FRGAP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRGAPJNJ
Forward yield7.95%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$98861.60M$30.5K
Annual income after 10y$96,529,713,962.19$4,749.88
Total dividends collected$98702.35M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: FRGAP vs JNJ ($10,000, DRIP)

YearFRGAP PortfolioFRGAP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,290$1,590.46$10,594$274.49+$1.7KFRGAP
2$16,805$3,653.73$11,294$360.69+$5.5KFRGAP
3$27,319$9,337.71$12,133$476.91+$15.2KFRGAP
4$57,605$28,373.85$13,156$635.42+$44.4KFRGAP
5$173,469$111,831.65$14,432$854.61+$159.0KFRGAP
6$815,080$629,468.71$16,056$1,162.76+$799.0KFRGAP
7$6,400,538$5,528,402.40$18,175$1,604.53+$6.38MFRGAP
8$87,993,624$81,145,048.06$21,009$2,252.68+$87.97MFRGAP
9$2,179,330,292$2,085,177,114.84$24,911$3,229.73+$2179.31MFRGAP
10$98,861,597,375$96,529,713,962.19$30,458$4,749.88+$98861.57MFRGAP

FRGAP vs JNJ: Complete Analysis 2026

FRGAPStock

Franchise Group, Inc. owns and operates franchised and franchisable businesses. It operates through six segments: Vitamin Shoppe, Pet Supplies Plus, Badcock, American Freight, Buddy's, and Sylvan. The Vitamin Shoppe segment operates as an omnichannel specialty retailer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products under the BodyTech, True Athlete, plnt, The Vitamin Shoppe, ProBioCare, Fitfactor Weight Management System, and Vthrive The Vitamin Shoppe brands. The Pet Supplies Plus segment operates as an omnichannel retail chain and franchisor of pet supplies and services that includes premium brands, proprietary private labels, and specialty products, as well as offers grooming, pet wash, and other services. The Badcock segment operates as a specialty retailer of furniture, appliances, bedding, electronics, home office equipment, accessories, and seasonal items in a showroom format; and offers multiple and flexible payment solutions and credit options through its consumer financing services. The American Freight segment operates a retail chain the provides in-store and online access to furniture, mattresses, new and out-of-box home appliances, and home accessories; and serves as a liquidation channel for appliance vendors. The Buddy's segment operates as a specialty retailer of consumer electronic, residential furniture, appliances, and household accessories through rent-to-own agreements. The Sylvan segment establishes and grows as a franchisor of supplemental education for Pre-K-12 students and families in the United States and Canada. The company was formerly known as Liberty Tax, Inc., and changed its name to Franchise Group, Inc. in September 2019. Franchise Group, Inc. was incorporated in 2010 and is headquartered in Delaware, Ohio.

Full FRGAP Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this FRGAP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRGAP vs SCHDFRGAP vs JEPIFRGAP vs OFRGAP vs KOFRGAP vs MAINFRGAP vs ABBVFRGAP vs MRKFRGAP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.